# Energy Focus, Inc: Form 10-Q for the period ended Jun 30, 2022

- Company: [Energy Focus, Inc](/companies/efoi.md) (CIK 924168)
- Form: 10-Q
- Filed: 2022-08-11
- Accepted by EDGAR: Aug 11, 2022, 08:02 ET
- Period: 2022-06-30
- Accession: 0000924168-22-000071
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/924168/000092416822000071/efoi-20220630.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/924168/000092416822000071/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2022-06-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2022-04-01 to 2022-06-30 | $1.5m | us-gaap:Revenues |
| Revenue | 6 months, 2022-01-01 to 2022-06-30 | $3.5m | us-gaap:Revenues |
| Cost of revenue | 3 months, 2022-04-01 to 2022-06-30 | $1.4m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 6 months, 2022-01-01 to 2022-06-30 | $3.5m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months, 2022-04-01 to 2022-06-30 | $109.0k | us-gaap:GrossProfit |
| Gross profit | 6 months, 2022-01-01 to 2022-06-30 | $83.0k | us-gaap:GrossProfit |
| Research and development | 3 months, 2022-04-01 to 2022-06-30 | $353.0k | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months, 2022-01-01 to 2022-06-30 | $856.0k | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months, 2022-04-01 to 2022-06-30 | $2.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months, 2022-01-01 to 2022-06-30 | $4.1m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2022-04-01 to 2022-06-30 | −$2.2m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months, 2022-01-01 to 2022-06-30 | −$4.9m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2022-04-01 to 2022-06-30 | $260.0k | us-gaap:InterestExpense |
| Interest expense | 6 months, 2022-01-01 to 2022-06-30 | $444.0k | us-gaap:InterestExpense |
| Net income | 3 months, 2022-04-01 to 2022-06-30 | −$2.5m | us-gaap:NetIncomeLoss |
| Net income | 6 months, 2022-01-01 to 2022-06-30 | −$5.3m | us-gaap:NetIncomeLoss |
| Diluted shares (weighted) | 3 months, 2022-04-01 to 2022-06-30 | 7,166,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months, 2022-01-01 to 2022-06-30 | 6,803,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months, 2022-04-01 to 2022-06-30 | −$2.6m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Operating cash flow | 6 months, 2022-01-01 to 2022-06-30 | −$5.3m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months, 2022-04-01 to 2022-06-30 | $2.0k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Capital expenditure | 6 months, 2022-01-01 to 2022-06-30 | $37.0k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | at 2022-06-30 | $938.0k | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2022-06-30 | $10.6m | us-gaap:AssetsCurrent |
| Total assets | at 2022-06-30 | $12.5m | us-gaap:Assets |
| Current liabilities | at 2022-06-30 | $6.4m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2022-06-30 | $8.3m | us-gaap:Liabilities |
| Shareholders' equity | at 2022-06-30 | $4.2m | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 48,172 characters.

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with the financial statements and related notes thereto included in Part I, Item 1, “Financial Statements” of this Quarterly Report, as well as Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” of our Annual Report on Form 10-K for the year ended December 31, 2021 (“2021 Annual Report”).

### Overview

Energy Focus, Inc. engages primarily in the design, development, manufacturing, marketing and sale of energy-efficient lighting and controls systems and ultraviolet-C light disinfection (“UVCD”) products. We develop, market and sell high quality light-emitting diode (“LED”) lighting and controls products and UVCD products in the commercial market and military maritime market (“MMM”), and expanded our offerings into the consumer market beginning in the fourth quarter of 2021. Our mission is to enable our customers to run their facilities, offices, homes and vessels with greater energy efficiency, productivity, and human health and wellness through advanced LED retrofit and UVCD solutions. Our goal is to be the human wellness lighting and LED lighting technology and market leader for the most demanding applications where performance, quality, value, environmental impact and health are considered paramount. We specialize in LED lighting retrofit by replacing fluorescent, high-intensity discharge lighting and other types of lamps in institutional buildings for primarily indoor lighting applications with our innovative, high-quality commercial and military-grade tubular LED (“TLED”) products, as well as other LED and lighting control products for commercial and consumer applications. In late 2020, we announced the launch of our UVCD product portfolio. With initial development complete and products now brought to market, we continue to evaluate the market demand for our UVCD products in 2022.

Net sales decreased 25% for the six months ended June 30, 2022 as compared to the six months ended June 30, 2021, primarily driven by a 47% decrease in MMM sales year-over-year, offset slightly by an increase in sales of our commercial products of 6%. The sales cycles for the MMM is dependent on many factors, including the availability and prioritization of government funding, the timing and fulfillment of U.S. Navy awards, new ship construction, diversion of funds to other government needs, and the timing of vessel maintenance schedules, and our financial results reflect volatility from fluctuations in the timing, pace and size of MMM projects. However, we reinvested in our MMM sales channel with a strategic hire in the second quarter of 2022 and continue to pursue these opportunities. In our commercial markets, while we are beginning to see an uptick in customer projects and purchase commitments, the sales cycles can range from several months to over one year and our financial results also reflect volatility from the continued fluctuations in the timing, pace and size of commercial projects due to, among other reasons, the long-term effects on our customers of the coronavirus (“COVID-19”) pandemic.

Operating losses increased by $0.3 million, or 7%, in the first six months of 2022 from the first six months of 2021. The Company’s results reflect the challenges due to long and unpredictable sales cycles, delays in customer retrofit budgets and project starts, and supply chain issues, primarily related to shipping costs exacerbated by the continuing effects of the COVID-19 pandemic. We have been challenged by continuing and intensifying aggressive price competition in the lighting industry, particularly in our retrofit market, as well as increased logistics expenses that are weighing on margins. We continued to incur losses and we have a substantial accumulated deficit, which continues to raise substantial doubt about our ability to continue as a going concern at June 30, 2022.

The COVID-19 pandemic in particular has, and may continue to have, a significant economic and business impact on us. We saw a slight improvement in commercial sales in the first half of 2022, following slowdowns in 2021 and 2020, as end customers in the healthcare, education, and commercial and industrial sectors delayed order placements in reaction to the impacts of the COVID-19 pandemic that caused our customers to suspend or postpone lighting retrofit projects due to budget and occupancy uncertainties. We remain cautious as our commercial sales reflect the volatility of large institutional end customers. Global supply chain and logistics challenges have further exacerbated slowdowns in customer projects, as well as impacted our margins, inventory and shipping strategies to respond to customer and supplier timelines.

We continue to monitor the impact of the COVID-19 pandemic on our customers, suppliers and logistics providers, and to evaluate governmental actions being taken in response to the pandemic. Global supply chain and logistics constraints are impacting our inventory purchasing strategy as we seek to manage both shortages of available components and longer lead times in obtaining components. Disruptions in global logistics networks are also impacting our lead times and ability to efficiently and cost-effectively transport products from our third-party suppliers to our facility. The significance and duration of the ongoing impact on us is still uncertain. Material adverse effects of the COVID-19 pandemic on market drivers, our customers, suppliers or logistics providers could significantly impact our operating results. We also plan to continue to actively follow, assess and analyze the long-term impact of the COVID-19 pandemic and stand ready to adjust our organizational structure, strategies, plans and processes to respond.

Because the situation continues to evolve, we cannot reasonably estimate the ultimate impact of the COVID-19 pandemic to our business, results of operations, cash flows and financial position. Continuation of the COVID-19 pandemic and its long-term impacts, as well as government actions in response thereto, could cause further disruptions to our operations and the operations of our customers, suppliers and logistics partners and could significantly adversely affect our near-term and long-term revenues, earnings, liquidity and cash flows. We will remain agile as an organization to respond to potential or continuing weakness in the macroeconomic environment and in the meantime expand sales channels and evaluate new markets, such as the UVCD and consumer markets that we believe may provide additional growth opportunities.

It is our belief that the momentum of the efforts undertaken in 2021, as described in our 2021 Annual Report, along with our continuing efforts to date in 2022, including the development and launch of new and innovative products such as our EnFocusTM powerline controls platform and the UVCD products, as well as our planned entry into the consumer markets with these new products, lowering of our fixed costs through improved lease arrangements beginning in the second half of the year, and our plans to shift to more cost effective in-bound freight strategies, will over time result in improved sales and bottom-line performance for the Company.

We launched our patented EnFocus™ powerline controls platform during the second quarter of 2020 and, despite the ongoing, significant delay and slowdown in our customers’ lighting projects following the impacts of the COVID-19 pandemic, we continue to receive positive feedback from the market through project specifications that are beginning to convert to larger volume orders. The EnFocus™ platform offers two immediately available product lines: EnFocus™ DM, which provides a dimmable lighting solution, and EnFocus™ DCT, which provides both a dimmable and color tunable lighting solution. EnFocus™ enables buildings to have dimmable, color tunable and circadian-ready lighting using existing wiring, without requiring additional data cables or any wireless communication systems, through a relatively simple upgrade with EnFocus™ switches and LED lamps. Our EnFocus™ powerline controls offer a more secure, affordable and environmentally sustainable solution compared with replacing entire lighting fixtures and incorporating additional wired or wireless communication.

In addition, in response to the COVID-19 pandemic and an anticipated increase in demand for air quality, sanitation and hygiene expectations for buildings, facilities and homes, we developed advanced UVCD air disinfection products for both consumer as well as the commercial and industrial markets. Two of these UVCD products were available beginning in the fourth quarter of 2021: the nUVo™ Traveler air disinfector, a portable air disinfection device for in-vehicle and other smaller locations and the nUVo™ Tower air disinfector, a portable air disinfection device for offices and homes. With initial development complete and two products now brought to market, we continue to evaluate the market demand for our UVCD products in 2022.

Throughout 2021, and continuing into the first six months of 2022, our MMM business continued to face challenges resulting from the delayed availability of government funding and the timing and prioritization of U.S. Navy awards, with several anticipated projects facing repeated and ongoing delays. We continue to pursue opportunities from the U.S. Navy and the government sector to minimize such volatility, and reinvested in our MMM sales channel with a strategic hire in the second quarter of 2022. Previously in our MMM business, significant efforts undertaken to reduce costs in our product offerings have positioned us to be more competitive along with improved production efficiencies. Additionally, we are an approved supplier for the General Services Administration (“GSA”) and many of our products are now listed in the GSA website for all federal and military agencies to view and order our products, a channel we hope to further develop. While we continue to aggressively seek to increase sales of our commercial products, we are reinvesting in the MMM business as we believe it offers us continued sales opportunities, in addition to validating our product quality and strengthening our brand trust in the marketplace. However, due to product mix impacts resulting from the continued impact of the COVID-19 pandemic on commercial sales, our current financial results are in part driven by, and reflect volatility in, our MMM sales.

Meanwhile, we continue to seek additional external funding alternatives and sources to support our growth strategies, plans and initiatives. We plan to achieve profitability through developing and launching new, innovative products such as EnFocusTM powerline controls, further leveraging our proprietary technology such as RedCap®, as well as executing on our multi-channel sales strategy that targets key verticals, such as government, healthcare, eldercare, education and commercial and industrial, complemented by our marketing outreach campaigns and expanding channel partnerships. We also plan to continue to develop advanced lighting and lighting control applications built upon the EnFocusTM platform that aim to serve both consumer and commercial markets. In addition, we intend to continue to apply rigorous financial discipline in our organizational structure, business processes and policies, strategic sourcing activities and supply chain practices to help accelerate our path towards profitability.

At June 30, 2022, we had $0.9 million in cash and a total of $4.5 million of debt, net of discounts and unamortized debt costs. Total debt, net of discounts and unamortized debt costs, at June 30, 2022 included $1.2 million outstanding under our inventory financing facility (the “Inventory Facility”), $0.7 million outstanding under our receivables financing facility (the “Receivables Facility” and, together with the Inventory Facility, the “Credit Facilities”), $0.8 million outstanding on the 2021 Streeterville Note (as defined below) and $1.8 million outstanding on the 2022 Streeterville Note (as defined below). At June 30, 2022, we had additional availability of $1.3 million under the Inventory Facility and $0.3 million under the Receivables Facility, for a total of $1.6 million of additional availability. Previously, on April 20, 2021, we entered into an amendment to the Loan and Security Agreement governing the Inventory Facility (the “Inventory Loan Agreement”) to increase the maximum amount that may be available to the Company from $3.0 million previously to $3.5 million, subject to the borrowing base as set forth in the Inventory Loan Agreement.

In June 2022, we completed a private placement (the “June 2022 Private Placement”) with certain institutional investors for the sale of 1,313,462 shares of our common stock at a purchase price of $1.30 per share. We also sold to the same institutional investors (i) pre-funded warrants (the “June 2022 Pre-Funded Warrants”) to purchase 1,378,848 shares of common stock at an exercise price of $0.0001 per share and (ii) warrants (collectively with the June 2022 Pre-Funded Warrants, the “June 2022 Warrants”) to purchase up to an aggregate of 2,692,310 shares of common stock at an exercise price of $1.30 per share. In connection with the June 2022 Private Placement, we paid the placement agent commissions of $252 thousand, plus $35 thousand in expenses, and we also paid legal, accounting and other fees of $47 thousand. Total offering costs of $334 thousand have been presented as a reduction of additional paid-in capital and have been netted within equity in the Condensed Consolidated Balance Sheet as of June 30, 2022. Net proceeds to us from the June 2022 Private Placement were approximately $3.2 million.

On April 21, 2022, we entered into a note purchase agreement (the “2022 Streeterville Note Purchase Agreement”) with Streeterville Capital, LLC (“Streeterville”) pursuant to which the Company sold and issued to Streeterville a promissory note in the principal amount of approximately $2.0 million (the “2022 Streeterville Note”). The 2022 Streeterville Note was issued with an original issue discount of $215 thousand and Streeterville paid a purchase price of $1.8 million for the 2022 Streeterville Note, after deduction of $15 thousand of Streeterville’s transaction expenses.

The 2022 Streeterville Note has a maturity date of April 21, 2024, and accrues interest at 8% per annum, compounded daily, on the outstanding balance. The Company may prepay the amounts outstanding under the 2022 Streeterville Note at a premium, which is 5% during the first six months and 8% thereafter. Prepayments at the reduced rate in the first six months are limited to 50% of the outstanding balance. Beginning on December 1, 2022, Streeterville may require the Company to redeem up to $225 thousand of the 2022 Streeterville Note in any calendar month. The Company has the right on five occasions, but not during more than three consecutive months, to defer all redemptions that Streeterville could otherwise require the Company to make during any calendar month. Each exercise of this deferral right by the Company will increase the amount outstanding under the 2022 Streeterville Note by 1.5%.

In December 2021, we completed a private placement (the “December 2021 Private Placement”) with certain institutional investors for the sale of 1,193,185 shares of our common stock at a purchase price of $3.52 per share. We also sold to the same institutional investors (i) pre-funded warrants (the “December 2021 Pre-Funded Warrants”) to purchase 85,228 shares of common stock at an exercise price of $0.0001 per share and (ii) warrants (collectively with the December 2021 Pre-Funded Warrants, the “December 2021 Warrants”) to purchase up to an aggregate of 1,278,413 shares of common stock at an exercise price of $3.52 per share. In connection with the December 2021 Private Placement, we paid the placement agent commissions of $360 thousand, plus $42 thousand in expenses, and we also paid legal, accounting and other fees of $97 thousand. Total offering costs of $499 thousand have been presented as a reduction of additional paid-in capital and have been netted within equity in the Condensed Consolidated Balance Sheet as of December 31, 2021. Net proceeds to us from the December 2021 Private Placement were approximately $4.0 million.

In June 2021, we completed a registered direct offering of 990,100 shares of our common stock to certain institutional investors, at a purchase price of $5.05 per share (the “June 2021 Equity Offering”). We paid the placement agent commissions of $400 thousand, plus $51 thousand in expenses, in connection with the June 2021 Equity Offering and we also paid legal and other fees of $18 thousand. Total offering costs of $469 thousand have been presented as a reduction of additional paid-in capital and have been netted within equity in the Condensed Consolidated Balance Sheet as of December 31, 2021. Net proceeds to us from the June 2021 Equity Offering were approximately $4.5 million.

On April 27, 2021, we entered into a note purchase agreement (the “2021 Streeterville Note Purchase Agreement”) with Streeterville pursuant to which the Company sold and issued to Streeterville a promissory note in the principal amount of approximately $1.7 million (the “2021 Streeterville Note”). The 2021 Streeterville Note was issued with an original issue discount of $194 thousand and Streeterville paid a purchase price of $1.5 million for the 2021 Streeterville Note, after deduction of $15 thousand of Streeterville’s transaction expenses.

The 2021 Streeterville Note has a maturity date of April 27, 2023, and accrues interest at 8% per annum, compounded daily, on the outstanding balance. The Company may prepay the amounts outstanding under the 2021 Streeterville Note at a premium, which is 5% during the first three months and 10% thereafter. Prepayments at the reduced rate in the first three months are limited to 50% of the outstanding balance. Beginning on the first day of the calendar month following the date that is six months after the date of purchase, Streeterville may require the Company to redeem up to $205 thousand of the 2021 Streeterville Note in any calendar month. The Company has the right on three occasions to defer all redemptions that Streeterville could otherwise require the Company to make during any calendar month. Each exercise of this deferral right by the Company will increase the amount outstanding under the 2021 Streeterville Note by 1.5%. The Company exercised this right twice during the fourth quarter of 2021 and once during the second quarter of 2022.

### Results of operations

The following table sets forth items in our Condensed Consolidated Statements of Operations as a percentage of net sales for the periods indicated:

|  | Three months ended June 30, 2022 | 2021 | Six months ended June 30, 2022 | 2021 |
| --- | ---: | ---: | ---: | ---: |
| **Net sales** | 100.0% | 100.0% | 100.0% | 100.0% |
| Cost of sales | 92.6 | 81.1 | 97.7 | 79.9 |
| **Gross profit** | 7.4 | 18.9 | 2.3 | 20.1 |
| **Operating expenses:** |  |  |  |  |
| Product development | 23.9 | 17.8 | 24.2 | 21.7 |
| Selling, general, and administrative | 132.7 | 109.4 | 115.5 | 95.2 |
| Restructuring recovery | — | (0.1) | — | (0.5) |
| **Total operating expenses** | 156.6 | 127.1 | 139.7 | 116.4 |
| **Loss from operations** | (149.2) | (108.2) | (137.4) | (96.3) |
| **Other expenses (income):** |  |  |  |  |
| Interest expense | 17.6 | 10.4 | 12.5 | 7.3 |
| Gain on forgiveness of Paycheck Protection Program loan | — | — | — | (17.0) |
| Other income | — | — | (0.8) | — |
| Other expenses | 1.2 | 0.7 | 0.8 | 0.7 |
| **Net loss** | (168.0)% | (119.3)% | (149.9)% | (87.3)% |

32

### Net sales

A further breakdown of our net sales is presented in the following table (in thousands):

|  | Three months ended June 30, 2022 | 2021 | Six months ended June 30, 2022 | 2021 |
| --- | ---: | ---: | ---: | ---: |
| Commercial | $975 | $1,078 | $2,109 | $1,991 |
| MMM products | 505 | 996 | 1,432 | 2,720 |
| **Total net sales** | $1,480 | $2,074 | $3,541 | $4,711 |

Net sales of $1.5 million for the second quarter of 2022 decreased $0.6 million, or 29%, compared to second quarter of 2021 net sales of $2.1 million, primarily driven by a decrease in MMM sales of $0.5 million, or 49%, and a decrease of $0.1 million, or 10%, of commercial products sales. Net MMM product sales decreased in the second quarter of 2022 compared to the same period in 2021, mainly due to availability and prioritization of government project funding and the delayed timing of expected orders. The decrease in commercial product sales in the second quarter of 2022 reflects (i) volatility of sales to large institutional customers; (ii) fluctuations in the timing and pace of commercial projects, including where lead times extended into the subsequent quarter; and (iii) lingering macroeconomic supply chain impacts as a result of the COVID-19 pandemic.

Net sales of $3.5 million for the first six months of 2022 decreased $1.2 million, or 25%, compared to the same period in 2021, primarily driven by a decrease in MMM product sales offset slightly by increased commercial sales. Net sales of our MMM products decreased mainly due to availability of government funding and the delayed timing of expected orders in the first six months of 2022. Net sales of our commercial products increased in the first six months of 2022 compared to the same period of 2021, reflecting the impact of increased commercial sales during the first quarter of 2022 as well as the impacts in the timing, pace and size of commercial projects.

### Gross Profit

Gross profit was $0.1 million, or 7.4% of net sales, for the second quarter of 2022. This compares with gross profit of $0.4 million, or 18.9% of net sales, in the second quarter of 2021. The year-over-year decrease in gross profit was driven by (i) lower sales volume, an unfavorable impact of $0.2 million, or 16% of net sales; and (ii) an unfavorable product mix impact of approximately $0.3 million, or 20% of net sales. These decreases were offset by a favorable net impact of $0.2 million, or 11% of net sales, from our inventory reduction project, with the change in inventory reserves offset by the inventory scrap write-off. Gross profit for the second quarter of 2022 also included unfavorable freight-in variances of $0.1 million, or 7% of net sales. Gross profit for the second quarter of 2021 included favorable price and usage variances for material and labor of $0.4 million, or 19% of net sales.

Gross profit was $0.1 million, or 2% of net sales, for the first six months of 2022 compared to $0.9 million, or 20% of net sales, for the first six months of 2021. The decrease was primarily related to (i) lower sales volume, which was an unfavorable impact of $0.5 million, or 13% of net sales; and (ii) an unfavorable impact from product mix of $0.6 million, or 17% of net sales. These decreases were offset by a favorable net impact of approximately $0.2 million, or 6% of net sales, from the change in inventory reserves offset by the inventory scrap write-off. The gross profit for the first six months of 2022 included unfavorable freight-in variances of $0.3 million, or 7% of net sales. Gross profit for the first six months of 2021 included favorable price and usage variances for material and labor of $0.6 million, or 12% of net sales, and unfavorable inventory and warranty reserves recorded of $0.1 million, or 2% of net sales.

### Operating expenses

#### Product development

Product development expenses include salaries and related expenses, contractor and consulting fees, legal fees, supplies and materials, as well as overhead, such as depreciation and facility costs. Product development costs are expensed as they are incurred.

Product development expenses were $0.4 million for the second quarter of 2022, down 5% from the second quarter of 2021. Product development expenses primarily relate to the development of our next generation of EnFocusTM and RedCap® products.

Product development expenses were $0.9 million for the first six months of 2022, a $0.2 million decrease compared to $1.0 million for the first six months of 2021. The decrease is primarily related to payroll expense and product testing associated with the development and launch of our UVCD product portfolio in 2021.

#### Selling, general and administrative

Selling, general and administrative expenses were $2.0 million for the second quarter of 2022, down 13% as compared to $2.3 million in the second quarter of 2021. The decrease in expenses from the second quarter of 2021 primarily relates to a reduction of $0.4 million in payroll and payroll related expenses. Other drivers of the change in expense in the second quarter of 2022 versus the second quarter of 2021 were increases of $0.1 million in each of consulting fees and trade show and marketing costs, offset by a decrease of $0.1 million in professional and filing fees.

Selling, general and administrative expenses were $4.1 million for the first six months of 2022, compared to $4.5 million for the first six months of 2021. The decrease is primarily due to decreases in payroll of $0.7 million, offset by increases in trade show and other marketing costs of $0.1 million, severance costs of $0.1 million and recruiting and relocation fees of $0.1 million.

#### Restructuring

No restructuring expense was recorded for the three and six months ended June 30, 2022. For the three months ended June 30, 2021, approximately $3 thousand in restructuring credits were recorded, and for the six months ended June 30, 2021, approximately $22 thousand in restructuring credits were recorded. All restructuring credits are related to the cost and offsetting sub-lease income for the lease obligations for the former New York, New York office, which ended as of June 30, 2021.

### Other Expense (Income)

#### Interest expense

Interest expense was $0.3 million for the second quarter of 2022, compared to interest expense of $0.2 million for the second quarter of 2021. The increase in interest expense is primarily related to interest and amortization attributable to the 2022 Streeterville Note. The actual cash interest paid in each of the second quarter of 2022 and the second quarter of 2021 was $0.1 million.

Interest expense was $0.4 million for the first six months of 2022, compared to interest expense of $0.3 million for the first six months of 2021. The increase in interest expense was primarily related to interest and amortization attributable to the 2022 Streeterville Note. The actual cash interest paid for each of the six months ended June 30, 2022 and the six months ended June 30, 2021 was $0.2 million.

#### Gain on forgiveness of PPP loan

Forgiveness income of $0.8 million related to the Paycheck Protection Program (“PPP”) loan taken out during 2020 and forgiven in 2021 was recognized during the first half of 2021.

#### Employee Retention Tax Credit

During the year ended December 31, 2021, we recognized other income of $876 thousand related to eligible Employee Retention Tax Credit (“ERTC”) expenses incurred during the second and third quarters of 2021 for which we became eligible.

#### Other income and expenses

Other expenses were $18 thousand for the second quarter of 2022, compared to other expenses of $15 thousand for the second quarter of 2021. Other expenses were $29 thousand for the six months ended June 30, 2022, compared to other expenses of $32 thousand for the six months ended June 30, 2021. Other expenses are mainly comprised of bank and collateral management fees.

Other income of $30 thousand for the first half of 2022 relates to an aged customer credit balance the Company had been carrying for which the customer had not responded to various inquiries. This credit was taken to income during the first quarter of 2022.

### Provision for income taxes

Due to the operating losses incurred during the three and six months ended June 30, 2022 and 2021, and after application of the annual limitation set forth under Section 382 of the Internal Revenue Code of 1986, as amended, it was not necessary to record a provision for U.S. federal income tax or various state income taxes as income tax benefits are fully offset by a valuation allowance recorded.

### Net loss

For the three months ended June 30, 2022, our net loss of $2.5 million increased 1% over the net loss for the three months ended June 30, 2021 of $2.5 million. The increase is mainly due to lower net sales in the second quarter of 2022.

For the six months ended June 30, 2022, our net loss of $5.3 million increased 29% over the net loss for the six months ended June 30, 2021 of $4.1 million. The increase is mainly due to lower net sales in the first half of 2022, and the gain on the forgiveness of the PPP loan of $0.8 million recorded in the first quarter of 2021.

### Financial condition

At June 30, 2022, we had $0.9 million in cash and a total of $4.5 million of debt, including $1.2 million outstanding under our Inventory Facility, $0.7 million outstanding under our Receivables Facility, $0.8 million outstanding on the 2021 Streeterville Note and $1.8 million outstanding on the 2022 Streeterville Note. At June 30, 2022, we had additional availability of $1.3 million under the Inventory Facility and $0.3 million under the Receivables Facility, for a total of $1.6 million of additional availability. We have historically incurred substantial losses, and as of June 30, 2022, we had an accumulated deficit of $144.0 million. Additionally, our sales have been concentrated among a few major customers and for the six months ended June 30, 2022, three customers accounted for approximately 42% of net sales.

As a result of the restructuring actions and initiatives described above, we have previously reduced our operating expenses to be more commensurate with our expected sales volumes. In the second quarter of 2022, we revisited cost reduction opportunities and further reduced operating expenses for the second half of 2022. However, we continue to incur losses and have a substantial accumulated deficit, and substantial doubt about our ability to continue as a going concern continues to exist at June 30, 2022.

Throughout 2021 and the first half of 2022, we have continued to evaluate and assess strategic options as we seek to achieve profitability. We plan to continue to develop advanced lighting and lighting control technologies and introduce impactful new products surrounding EnFocusTM, our patented, breakthrough powerline control platform. We also continue to believe our proprietary RedCap® emergency backup lighting system also addresses a market need and will continue to help drive commercial sales for us as it has been well received in the market.

We brought the first of our UVCD products, the nUVo™ Traveler portable personal air disinfection device for in-vehicle and smaller spaces and the nUVo™ Tower portable air disinfection device for offices and homes, to market beginning in the fourth quarter of 2021, and we continue to evaluate market demand for our products in 2022. Our UVCD product line represents a new category of human wellness products. Initial sales in the first half of 2022 as we seek market traction have not contributed significantly to our results of operations.

We plan to achieve profitability by growing our sales through existing and new lighting and control systems products, and by continuing to refine and execute on our multi-channel sales strategy that targets key verticals, such as government, healthcare, eldercare, education, and commercial and industrial, complemented by our marketing outreach campaigns and expanding channel partnerships, as well as our emerging consumer market focus.

As described in Note 9, “Stockholders’ Equity,” we also raised approximately $3.2 million of net proceeds upon the issuance of common stock and June 2022 Warrants in connection with the June 2022 Private Placement, $4.0 million of net proceeds upon the issuance of common stock and December 2021 Warrants in connection with the December 2021 Private Placement, and approximately $4.5 million of net proceeds upon the issuance of common stock in connection with the June 2021 Equity Offering. As described in Note 7, “Debt”, in April 2022 and April 2021, we obtained net proceeds of approximately $1.8 million and $1.5 million of bridge financing, respectively. Also in April 2021, we expanded the borrowing capacity on one of our revolving credit facilities.

The restructuring and cost cutting initiatives taken throughout 2021 and continuing into 2022, as well as the June 2022 Private Placement, the December 2021 Private Placement and the June 2021 Equity Offering that strengthened our balance sheet, our credit facility capacity increase and bridge financing in April 2021 and April 2022, and the funds we expect to receive related to the Employee Retention Tax Credit (“ERTC”; see Note 11, “Other Income” for details), were all designed to allow us to effectively execute these strategies. However, our efforts may not occur as quickly as we envision or be successful due to the long sales cycle in our industry, the corresponding time required to ramp up sales from new products, markets, and customers into this sales cycle, the timing of introductions of additional new products, significant competition, potential sales volatility given our customer concentration, numerous interruptions and cost increases in the supply chain globally, and the long-term economic impact from the COVID-19 pandemic that has significantly diminished the interest and activities for our customers’ lighting retrofit projects until occupancy returns to more normal levels, among other factors.

Additionally, global supply chain and logistics constraints are impacting our inventory purchasing strategy, as we seek to manage both shortages of available components and longer lead times in obtaining components while balancing the development and implementation of an inventory reduction plan. Disruptions in global logistics networks are also impacting our lead times and ability to efficiently and cost-effectively transport products from our third-party suppliers to our facility. As a result, we will continue to review and pursue selected external funding sources to ensure adequate financial resources to execute across the timelines required to achieve these objectives including, but not limited to, the following:

- obtaining financing from traditional or non-traditional investment capital organizations or individuals;
- obtaining funding from the sale of our common stock or other equity or debt instruments; and
- obtaining debt financing with lending terms that more closely match our business model and capital needs.

There can be no assurance that we will obtain funding on acceptable terms, in a timely fashion, or at all. Obtaining additional funding contains risks, including:

- additional equity financing may not be available to us on satisfactory terms, and any equity we are able to issue could lead to dilution for current stockholders and have rights, preferences and privileges senior to our common stock;
- loans or other debt instruments may have terms and/or conditions, such as interest rate, restrictive covenants, conversion features, refinancing demands, and control or revocation provisions, which are not acceptable to management or our board of directors; and
- the current environment in the capital markets and volatile interest rates, combined with our capital constraints, may prevent us from being able to obtain adequate debt financing.

If we are unable to find a permanent Chief Executive Officer and permanent Chief Financial Officer, it may be more difficult to obtain additional financing on satisfactory terms or at all. If we fail to obtain the required additional financing to sustain our business before we are able to produce levels of revenue to meet our financial needs, we will need to delay, scale back or eliminate our growth plans and further reduce our operating costs and headcount, each of which would have a material adverse effect on our business, future prospects, and financial condition. A lack of additional funding could also result in our inability to continue as a going concern and force us to sell certain assets or discontinue or curtail our operations and, as a result, investors in the Company could lose their entire investment.

Considering both quantitative and qualitative information, we continue to believe that the combination of our plans to ensure adequate external funding, timely re-organizational actions, current financial position, liquid resources, obligations due or anticipated within the next year, development and implementation of an excess inventory reduction plan, plans and initiatives in our research and development, product development and sales and marketing, and development of potential channel partnerships, if adequately executed, will provide us with an ability to finance our operations through the next twelve months and will mitigate the substantial doubt about our ability to continue as a going concern.

On August 17, 2020, we received a letter from the Listing Qualifications staff (the “Staff”) of The Nasdaq Stock Market (“Nasdaq”) notifying us that we were no longer in compliance with Nasdaq Listing Rule 5550(b)(1), which requires listed companies to maintain stockholders’ equity of at least $2,500,000 if they do not meet the alternative compliance standards relating to the market value of listed securities or net income from continuing operations (the “Minimum Stockholders’ Equity Rule”). Our Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2020, filed on August 13, 2020, reflected that our stockholders’ equity as of June 30, 2020 was $1,714,000. Based on our timely submission of our plan to regain compliance, Nasdaq granted us an extension through February 15, 2021 to regain compliance with the Minimum Stockholders’ Equity Rule. In accordance with one part of the plan submitted to the Staff, we successfully modified our outstanding January 2020 Warrants and in December 2020, we reclassified $1.4 million from warrant liability into equity. On January 20, 2021, we received a letter from the Staff notifying us that, on a conditional basis, Nasdaq has determined that we have regained compliance with the Minimum Stockholders’ Equity Rule. At December 31, 2020, our stockholders’ equity was $4,255,000, satisfying the Minimum Stockholders’ Equity Rule. At December 31, 2021, our stockholders’ equity was $6,209,000 and at June 30, 2022, our stockholders’ equity was $4,171,000.

### Liquidity and capital resources

#### Cash

At June 30, 2022, our cash balance was approximately $0.9 million, compared to approximately $2.7 million at December 31, 2021.

The following summarizes cash flows from operating, investing, and financing activities, as reflected in the Condensed Consolidated Statements of Cash Flows included in Part I, Item 1, “Financial Statements,” of this Quarterly Report (in thousands):

|  | Six months ended June 30, 2022 | 2021 |
| --- | ---: | ---: |
| Net cash used in operating activities | $(5,345) | $(6,105) |
| Net cash used in investing activities | $(37) | $(211) |
| Net cash provided by financing activities | $3,638 | $5,807 |

#### Net cash used in operating activities

Net cash used in operating activities was $5.3 million for the six months ended June 30, 2022. The net loss was $5.3 million and was adjusted for non-cash items, including depreciation and amortization, stock-based compensation, provisions for inventory, warranty, and accounts receivable reserves and working capital changes. During the six months ended June 30, 2022, we generated $0.8 million from inventory, $0.1 million through the timing of collection of accounts receivable, and $0.1 million from changes in prepaid and other assets. We used $0.7 million from accounts payable due to the timing of inventory receipts and payments, $0.4 million due to changes in accrued and other liabilities (primarily due to a decrease in accrued payroll), and $0.3 million from changes in deferred revenue.

Net cash used in operating activities was $6.1 million for the six months ended June 30, 2021. The net loss was $4.1 million and was adjusted for non-cash items, including depreciation and amortization, stock-based compensation, provisions for inventory, warranty, gain on forgiveness of the PPP loan and accounts receivable reserves and working capital changes. During the six months ended June 30, 2021, we generated $0.9 million through the timing of collection of accounts receivable and $0.1 million through the timing of the receipt of inventory against short-term deposits. We used $2.5 million for inventory primarily due to global supply chain challenges we experienced, which impacted our inventory purchasing strategy, in an effort to manage both shortages of available components and longer lead times in obtaining components. We used $0.4 million due to changes in accrued and other liabilities (primarily due to a reduction of $0.1 million in accrued accounting and legal fees and $0.3 million in accrued bonuses).

#### Net cash used in investing activities

Net cash used in investing activities was $37 thousand for the six months ended June 30, 2022 and resulted primarily from the purchase of tooling.

For the six months ended June 30, 2021, net cash used in investing activities was $211 thousand and resulted primarily from the purchase of software and a vehicle to support production operations, as well as development of the e-commerce platform.

#### Net cash provided by financing activities

Net cash provided by financing activities during the six months ended June 30, 2022 was $3.6 million, primarily related to net proceeds of $1.8 million from the 2022 Streeterville Note and net proceeds of $3.2 million from the June 2022 Private Placement. These proceeds were offset slightly by $1.0 million in payments made against the 2021 Streeterville Note and $0.3 million in net payments made on the Credit Facilities.

During the six months ended June 30, 2022, all of the December 2021 Pre-Funded Warrants were exercised. As of June 30, 2022, June 2022 Warrants to purchase an aggregate of 4,071,158 shares remained outstanding, with a weighted average exercise price of $0.86 per share. The exercise of the remaining June 2022 Warrants outstanding could provide us with cash proceeds of up to $3.5 million in the aggregate. Also at June 30, 2022, December 2021 Warrants to purchase an aggregate of 1,278,413 shares remained outstanding with an exercise price of $3.52 per share. January 2020 Warrants to purchase an aggregate of 229,414 shares remain outstanding at June 30, 2022, with a weighted average exercise price of $3.67 per share. The exercise of the remaining outstanding December 2021 Warrants and January 2020 Warrants could provide us with cash proceeds of up to $4.5 million and $0.8 million, respectively.

Net cash provided by financing activities during the six months ended June 30, 2021 was $5.8 million, primarily related to $4.5 million of net proceeds from the June 2021 Equity Offering, $1.5 million of net proceeds from the 2021 Streeterville Note, and proceeds from the exercise of 156,446 warrants of $0.5 million. These sources of cash were partially offset by net payments on the Credit Facilities of $0.8 million. Investors in the January 2020 Equity Offering received warrants to purchase shares of our common stock, of which warrants to purchase an aggregate of 310,860 shares remained outstanding at June 30, 2021 with a weighted average exercise price of $3.59 per share.

#### Contractual and other obligations

As of June 30, 2022, we had approximately $0.8 million in outstanding purchase commitments for inventory, all of which is expected to ship in the third quarter of 2022.

There have been no other material changes to our contractual and other obligations as compared to those included in our 2021 Annual Report.

### Critical accounting policies

There have been no material changes to our critical accounting policies as compared to those included in our 2021 Annual Report.

### Certain risks and concentrations

We have certain customers whose net sales individually represented 10% or more of our total net sales, or whose net trade accounts receivable balance individually represented 10% or more of our total net trade accounts receivable; we have certain suppliers, which individually represent 10% or more of our total purchases, or whose trade accounts payable balance individually represented 10% or more of our total trade accounts payable balance, as follows:

For the three months ended June 30, 2022, sales to our primary distributor for the U.S. Navy, a regional commercial lighting retrofit company, and a commercial building systems provider accounted for approximately 22%, 14%, and 13% of net sales, respectively. When sales to our primary distributor for the U.S. Navy are combined with sales to shipbuilders for the U.S. Navy, total net sales of products for the U.S. Navy comprised approximately 24% of net sales for the same period. For the three months ended June 30, 2021, sales to our primary distributor for the U.S. Navy and a regional commercial lighting retrofit company accounted for approximately 30% and 10% of net sales, respectively. When sales to our primary distributor for the U.S. Navy are combined with sales to shipbuilders for the U.S. Navy, total net sales of products for the U.S. Navy comprised approximately 35% of net sales for the same period. For the six months ended June 30, 2022, sales to our primary distributor for the U.S. Navy, a U.S. Navy shipbuilder, and a regional commercial lighting retrofit company accounted for approximately 18%, 12%, and 12% of net sales, respectively. When sales to our primary distributor for the U.S. Navy are combined with sales to shipbuilders for the U.S. Navy, total net sales of products for the U.S. Navy comprised approximately 31% of net sales for the same period.

For the six months ended June 30, 2021, sales to our primary distributor for the U.S. Navy and a regional commercial lighting retrofit company accounted for approximately 41% and 11% of net sales, respectively. When sales to our primary distributor for the U.S. Navy are combined with sales to shipbuilders for the U.S. Navy, total net sales of products for the U.S. Navy comprised approximately 47% of net sales for the same period.

A regional commercial lighting retrofit company and two commercial building systems providers accounted for approximately 17%, 34%, and 14% of net trade accounts receivable, respectively, at June 30, 2022. At December 31, 2021, a distributor to the U.S. Department of Defense accounted for 20% of our net trade accounts receivable and a shipbuilder for the U.S. Navy accounted for 36% of our net trade accounts receivable.

Two offshore suppliers accounted for approximately 19% and 10% of our total expenditures for the three months ended June 30, 2022. For the six months ended June 30, 2022, one offshore supplier accounted for approximately 19% of our total expenditures. For the three and six months ended June 30, 2021, one offshore supplier accounted for approximately 39% and 32%, respectively, of total expenditures.

At June 30, 2022, one offshore supplier accounted for approximately 53% of our trade accounts payable balance. At December 31, 2021, this offshore supplier accounted for approximately 60% of our trade accounts payable balance.

### Recent accounting pronouncements

For information on recent accounting pronouncements, please refer to Note 2, “Basis of Presentation and Summary of Significant Accounting Policies,” included under Part I, Item 1, “Financial Statements,” of this Quarterly Report.

## Market risk

As filed, 147 characters.

As a “smaller reporting company” as defined by Item 10 of Regulation S-K, the Company is not required to provide information required by this item.

## Controls and procedures

As filed, 1,664 characters.

### Evaluation of disclosure controls and procedures

We maintain disclosure controls and procedures, as defined in Rule 13a-15(e) and Rule 15d-15(e) under the Exchange Act that are designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the Securities and Exchange Commission, and that such information is accumulated and communicated to management, including our Interim Chief Executive Officer who also serves as our principal financial officer, as appropriate, to allow for timely decisions regarding required disclosure.

Pursuant to Rule 13a-15(b) under the Exchange Act, our management must evaluate, with the participation of our Interim Chief Executive Officer, the effectiveness of our disclosure controls and procedures, as of June 30, 2022, the end of the period covered by this Quarterly Report. Management, with the participation of our Interim Chief Executive Officer, did evaluate the effectiveness of our disclosure controls and procedures as of the end of period covered by this Quarterly Report. Based on this evaluation, our Interim Chief Executive Officer concluded that our disclosure controls and procedures were effective as of June 30, 2022.

### Changes in internal control over financial reporting

During the quarterly period covered by this Quarterly Report, there have not been any changes in our internal control over financial reporting that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

## Risk factors

As filed, 147 characters.

As a “smaller reporting company” as defined by Item 10 of Regulation S-K, the Company is not required to provide information required by this item.

Filed Aug 11, 2022.
Source: SEC EDGAR, the filing index for accession 0000924168-22-000071. Last ingested by Listed: Nov 10, 2026, 16:57 ET. No prices; not investment advice.
